Sagility Limited (BOM:544282)
India · Delayed Price · Currency is INR 45.22
-0.70 (-1.52%)
At close: Oct 28, 2026
Sagility Revenue
Sagility had revenue of 20.32B INR in the quarter ending September 30, 2026, with 22.53% growth. This brings the company's total for the last twelve months to 79.91B, up 28.49% year-over-year. In the fiscal year ending March 31, 2026, Sagility had annual revenue of 71.93B with 29.14% growth.
Revenue (ttm)
79.91B
Revenue Growth
+28.49%
P/S Ratio
2.65
Revenue / Employee
1.55M
Employees
51,486
Market Cap
212.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 71.93B | 16.23B | 29.14% |
| Mar 31, 2025 | 55.70B | 8.16B | 17.17% |
| Mar 31, 2024 | 47.54B | 5.35B | 12.69% |
| Mar 31, 2023 | 42.18B | 28.33B | 204.55% |
| Mar 31, 2022 | 13.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Zydus Lifesciences | 285.92B |
| Divi's Laboratories | 112.30B |
| Lenskart Solutions | 96.34B |
| Piramal Pharma | 92.05B |
| Sagility | 79.91B |
| Krishna Institute of Medical Sciences | 42.13B |
| Pfizer | 25.70B |
Sagility News
- 6 days ago - Sagility Transcript: Q2 26/27 - Transcripts
- 6 days ago - Sagility Quarterly report: Q2 2027 - Filings
- 6 days ago - Sagility Slides: Q2 2027 - Filings
- 3 months ago - Sagility Transcript: Q1 26/27 - Transcripts
- 3 months ago - Sagility Quarterly report: Q1 2027 - Filings
- 3 months ago - Sagility Slides: Q1 2027 - Filings
- 5 months ago - Sagility Transcript: Q4 25/26 - Transcripts
- 5 months ago - Sagility Quarterly report: Q4 2026 - Filings